Suppr超能文献

梅州地区α-和β-地中海贫血的分子分析及与中国南方不同地区基因突变谱的比较。

Molecular analysis of alpha- and beta-thalassemia in Meizhou region and comparison of gene mutation spectrum with different regions of southern China.

机构信息

Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, China.

Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, China.

出版信息

J Clin Lab Anal. 2021 Dec;35(12):e24105. doi: 10.1002/jcla.24105. Epub 2021 Nov 9.

Abstract

BACKGROUND

Thalassemia is a group of inherited autosomal recessive hemolytic anemia disease caused by reduced or absent synthesis of globin chain/chains of hemoglobin. Only few studies showed the molecular characterization of α- and β-thalassemia in Meizhou city of China.

METHODS

A total of 22,401 individuals were collected; hematological and hemoglobin electrophoresis analysis and thalassemia genetic testing were performed.

RESULTS

Eleven thousand and thirty (49.24%) cases with microcytosis (mean corpuscular volume (MCV) < 82 fl), 11,074 (49.44%) cases with hypochromia (mean corpuscular Hb (MCH) < 27 pg) in 22,401 subjects, 11,085 cases with abnormal hemoglobin results were identified in subjects aged ≥6 months. 7,322 (32.69%) subjects harbored thalassemia mutations, including 4,841 (21.61%) subjects with α-thalassemia, 2,237 (9.99%) with β-thalassemia, and 244 (1.09%) with α-thalassemia combined β-thalassemia. 18 genotypes of α-thalassemia mutations and 27 genotypes of β-thalassemia mutations were characterized. The most frequent α gene mutation was -- (64.69%), followed by -α (19.93%), -α (7.73%), α α (3.97%), and α α (2.83%). The six most common β-thalassemia mutations were IVS-II-654 (C>T) (39.79%), CD41-42 (-TCTT) (33.02%), -28 (A>G) (10.38%), CD17 (A>T) (9.08%), CD27-28 (+C) (2.14%), and CD26 (G>A) (2.02%). In addition, MCV and MCH were sensitive markers for α- and β-thalassemia except for -α /αα, -α /αα, α α/αα, α α/αα, and β /β .

CONCLUSIONS

The -- , -α , and -α deletions were the main mutations of α-thalassemia, while IVS-II-654 (C>T), CD41-42 (-TCTT), -28 (A>G), and CD17 (A>T) mutations of β-thalassemia in Meizhou. There were some differences in thalassemia mutation frequencies in Meizhou city from other populations in China.

摘要

背景

地中海贫血是一组由珠蛋白链/血红蛋白链合成减少或缺失引起的遗传性常染色体隐性溶血性贫血疾病。只有少数研究显示了中国梅州市的α-和β-地中海贫血的分子特征。

方法

共收集 22401 人;进行血液学和血红蛋白电泳分析以及地中海贫血基因检测。

结果

在 22401 名受试者中,有 11030 名(49.24%)存在小细胞症(平均红细胞体积(MCV)<82fl),11074 名(49.44%)存在低色素性(平均红细胞 Hb(MCH)<27pg),在年龄≥6 个月的受试者中发现 11085 例异常血红蛋白结果。7322 例(32.69%)受试者携带有地中海贫血突变,包括 4841 例(21.61%)α-地中海贫血,2237 例(9.99%)β-地中海贫血,244 例(1.09%)α-地中海贫血合并β-地中海贫血。鉴定出 18 种α-地中海贫血突变和 27 种β-地中海贫血突变。最常见的α基因突变是--(64.69%),其次是-α(19.93%)、-α(7.73%)、αα(3.97%)和αα(2.83%)。六种最常见的β-地中海贫血突变是 IVS-II-654(C>T)(39.79%)、CD41-42(-TCTT)(33.02%)、-28(A>G)(10.38%)、CD17(A>T)(9.08%)、CD27-28(+C)(2.14%)和 CD26(G>A)(2.02%)。此外,MCV 和 MCH 除了-α/αα、-α/αα、αα/αα、αα/αα 和-β/β之外,是α-和β-地中海贫血的敏感标志物。

结论

在梅州市,-、-α 和-α 缺失是α-地中海贫血的主要突变,而 IVS-II-654(C>T)、CD41-42(-TCTT)、-28(A>G)和 CD17(A>T)突变是β-地中海贫血的主要突变。梅州市地中海贫血突变频率与中国其他人群存在一些差异。

相似文献

5
[Analysis of the Types of Thalassemia Gene Mutations in Nanping Area of Fujian, China].[中国福建南平地区地中海贫血基因突变类型分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Jun;28(3):918-926. doi: 10.19746/j.cnki.issn.1009-2137.2020.03.033.
7
[Molecular epidemiological analysis of α- and β-thalassemia in Fujian province].福建省α和β地中海贫血的分子流行病学分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Aug;30(4):403-6. doi: 10.3760/cma.j.issn.1003-9406.2013.04.005.

本文引用的文献

2
Update in Laboratory Diagnosis of Thalassemia.地中海贫血实验室诊断的最新进展。
Front Mol Biosci. 2020 May 27;7:74. doi: 10.3389/fmolb.2020.00074. eCollection 2020.
10
The α-thalassemias.α-地中海贫血症。
N Engl J Med. 2014 Nov 13;371(20):1908-16. doi: 10.1056/NEJMra1404415.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验